Volpinacci

Andrew Grant Joined Feb 05, 2012

Investor. Options swing-trader. Using out of the box, equity-specific TA: Volpinacci's new math. Abolitionist of the corrupt 2 parties system. Voting Libertarian.

Followers

  1. Thumb-1393280674
    Hozercoop21
    Brandon Cooper
    Just a hardworking husband and soon to be father.
  2. Thumb-1407156870
  3. Default_avatar_thumb
    lonewolfe
    Henry Wolfe
  4. Thumb-1411098536
    diazr11
    Ramona Diaz
  5. Thumb-1375382694
    InvisibleTrades
    Invisible Trades
    Burning Shorts Worldwide. Networked With Strong Hedge Fund Short Busters. Warning: When I Appear You Will Know It.
  6. Default_avatar_thumb
    TexasBeta
    TexasBeta
  7. Thumb-1393459283
    DavidRoland
    David Roland
  8. Default_avatar_thumb
    Broohaha
    Broohaha
  9. Default_avatar_thumb
    dlyte
    Dlyte
  10. Thumb-1382588711
    edster1200
    ed stillings
  11. Thumb-1413608269
    PurpleBuLL
    rudolf
  12. Thumb-1392173379
    mildlybullish
    Mildlybullish
    Use our free covered call screener to earn extra income from stocks and ETFs you already own, or to help find stocks for selling the best covered calls.
  13. Thumb-1391039256
    gmoney23
    Greg Benedetto
  14. Thumb-1392131590
    StatPro_Tom
    Thomas Leatherman
    StatPro Revolution : Portfolio Analysis that Promotes the Network Effect which = $$$$$$$$ 617-692-1141 thomas.leatherman@statpro.com Opinions are my own. Trade at your own discretion.
  15. Thumb-1361397177
    forefun
    Brad Hill
    intrigued by the markets and trading from age 20, CPA (inactive), former financial planner for AXP sub, wide industry exposures, swimming the stream to live in the future - utilizing constant Discovery & Alignment thru Technologic Application
  16. Default_avatar_thumb
    Bogey45
    Eric
  17. Default_avatar_thumb
    vincehaveph8
    Vince
  18. Thumb-1391058895
    Endorphin
    Endo Orphin
  19. Thumb-1381497801
    wspunk
    wspunk
  20. Thumb-1387946012
    kiariepaul
    paul
    biotech catalysts: clinical (phase1, phase2, phase 3); regulatory (nda, adcom, pdufa); commercialization (partnership, buy-out, roll-out) pharmD
threw